Cargando…
Cytokine and Lipid Mediator Regulation of Group 2 Innate Lymphoid Cells (ILC2s) in Human Allergic Airway Disease
The recent discovery of group 2 innate lymphoid cells (ILC2s) has caused a paradigm shift in the understanding of allergic airway disease pathogenesis. Prior to the discovery of ILC2s, Th2 cells were largely thought to be the primary source of type 2 cytokines; however, activated ILC2s have since be...
Autores principales: | Cavagnero, Kellen, Doherty, Taylor A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5614509/ https://www.ncbi.nlm.nih.gov/pubmed/28959799 |
Ejemplares similares
-
Cyclic-di-GMP Induces STING-Dependent ILC2 to ILC1 Shift During Innate Type 2 Lung Inflammation
por: Cavagnero, Kellen J., et al.
Publicado: (2021) -
Innate Lymphoid Cells (ILCs) as Mediators of Inflammation, Release of Cytokines and Lytic Molecules
por: Elemam, Noha Mousaad, et al.
Publicado: (2017) -
Type 2 Innate Lymphoid Cells in Allergic Disease
por: Lund, Sean, et al.
Publicado: (2013) -
The histone deacetylase inhibitor trichostatin A suppresses murine innate allergic inflammation by blocking group 2 innate lymphoid cell (ILC2) activation
por: Toki, Shinji, et al.
Publicado: (2016) -
Group 2 Innate Lymphoid Cells (ILC2): Type 2 Immunity and Helminth Immunity
por: Herbert, De’Broski R., et al.
Publicado: (2019)